Table 3. HCC sample cohorts used for analysis of TGF-β1 and TGF-β2 expression.
| Publication | Array Name |
N°HCC Patients | HCC Etiologies | Normal Liver | Surrounding Tissue |
|---|---|---|---|---|---|
| Roessler S. Cancer Res. 2010 [79] | GSE14520 | 247 | HBV | 247 | |
| Wang XW. Clin Cancer Res., 2007 [83] | GSE5975 | 236 | Ep_CAM +/−; HBV+; Cirrhosis +/− | 236 | |
| Thorgeirsson S. Nature Genetics 2004 [84] | GSE1898 | 91 | HBV+; HCV+; co-infection; HBV/Alcohol; HCV/Alcohol, Hemochromatosis | 91 | |
| Neumann O. Hepatology 2012 [85] | GSE50579 | 40 | HBV+; HCV+; co-infection; Alcohol; Cryptogenic; Hemochromatosis; Others | 7 | |
| Shimokawa K. BMC Genomics. 2010 [86] | iCOD | 140 | HBV+; HCV+; co-infection; Alcohol; HCV+ Alcohol, Diabetes; Cirrhosis; Unknown | NA | |
| Thorgeirsson S. Nature Genetics 2004 [84] Lee JS et al. Nat Med 2006 [87] |
GSE4024/GSE1898 | 142 | HBV+; HCV+; co-infection; Alcohol; Cryptogenic; Hemochromatosis; ALD; NASH; Adenoma; Autoimmune; Unknown; Others | 10 |
NA = not announced in the study.